Randomised, Mulit-centre, Prospective, Two-Arm, Open-Label, Phase 2 Study to Investigate the Efficacy & Safety of Two ZAK 219477 i.v Infusions in Patients with Recurrent Ovarian Cancer Progressing During, or Within 6 Months of the End....

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleRandomised, Mulit-centre, Prospective, Two-Arm, Open-Label, Phase 2 Study to Investigate the Efficacy & Safety of Two ZAK 219477 i.v Infusions in Patients with Recurrent Ovarian Cancer Progressing During, or Within 6 Months of the End....
StatusFinished
Effective start/end date1/01/06 → 31/03/07

Funding

  • SCHERING HEALTH CARE LTD